Edwards Lifesciences (EW)
80.00
+4.20 (5.54%)
NYSE · Last Trade: Jul 26th, 3:11 AM EDT
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · July 25, 2025
Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue growth.
Via Benzinga · July 25, 2025
Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in Friday's midday trading as optimism over corporate earnings and progress on global trade talks provided support for risk assets.
Via Benzinga · July 25, 2025
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · July 25, 2025
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · July 25, 2025
Via Benzinga · July 25, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via Chartmill · July 25, 2025
Via Benzinga · July 25, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.
Via Chartmill · July 24, 2025
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · July 24, 2025
Edwards Lifesciences stock jumped late Thursday.
Via Investor's Business Daily · July 24, 2025

EDWARDS LIFESCIENCES CORP (NYSE:EW) shows strong technicals and a high-quality setup, making it a potential breakout candidate for traders.
Via Chartmill · June 5, 2025

The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
Via Stocktwits · May 28, 2025

The company said the regulatory path forward for one of its key systems is too murky to pursue.
Via Investor's Business Daily · May 28, 2025
Via Benzinga · May 22, 2025
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.
Via Chartmill · May 20, 2025
Edwards Lifesciences (NYSE:EW) shows strong technicals and a consolidation pattern, making it a breakout candidate. Resistance at $76.76 could signal further upside if broken.
Via Chartmill · May 15, 2025
Via Benzinga · May 7, 2025
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.
Via Chartmill · April 24, 2025